NIH-funded research R01 grant

Investigating how a virus contributes to certain lymphomas in AIDS patients

Official title: Exposing synthetic lethal vulnerabilities in EBV-positive AIDS-NHL through novel replication dependency factors

Funded at University of Florida · NIH-10919868 · Data updated 2026-11-12

This study is looking at how the Epstein-Barr virus might help cause lymphomas in people with HIV/AIDS, and it aims to find new ways to treat these cancers by discovering important proteins involved in this process.

More AIDS research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 4, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$599,564
NIH project number5R01DE032623-02
Project IDNIH-10919868 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with HIV/AIDS who have developed EBV-positive lymphomas.

Less likely to help

Patients without HIV/AIDS or those with lymphomas not associated with EBV may not benefit from this research.

What this research studies

This research focuses on understanding how the Epstein-Barr virus (EBV) contributes to the development of lymphomas in individuals with HIV/AIDS. The study aims to explore the mechanisms by which EBV drives the replication of cancer cells, particularly in B cells, and how these cancer cells manage replication stress. By utilizing advanced techniques like mass spectrometry, researchers hope to identify novel proteins that play a critical role in this process, potentially leading to new therapeutic targets for treatment.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies for patients with EBV-positive AIDS-related lymphomas.

How similar studies have gone: While the specific approach of targeting EBV-driven replication stress is novel, previous research has shown promise in understanding virus-associated cancers.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Bhaduri-Mcintosh, Sumita — University of Florida
  • Study coordinator: Bhaduri-Mcintosh, Sumita

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.